
Biofrontera
(NASDAQ) BFRI
Biofrontera Financials at a Glance
Market Cap
$9.59M
Revenue (TTM)
$41.71M
Net Income (TTM)
$10.54M
EPS (TTM)
$-1.18
P/E Ratio
-0.70
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.82
Volume
0
Open
$0.81
Price
$0.82
Volume
0
Open
$0.81
Previous Close
$0.82
Daily Range
$0.81 - $0.82
52-Week Range
$0.54 - $1.19
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.82
Volume
0
Open
$0.81
Previous Close
$0.82
Daily Range
$0.81 - $0.82
52-Week Range
$0.54 - $1.19
BFRI News
BFRI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biofrontera
Industry
Pharmaceuticals
Sector
Health CareEmployees
92
CEO
Hermann Lübbert, PhD
Website
www.biofrontera-us.comHeadquarters
Woburn, MA 01801, US
BFRI Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
-27%
Net Income Margin
-25%
Return on Equity
-141%
Return on Capital
-68%
Return on Assets
-37%
Earnings Yield
-1.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.59M
Shares Outstanding
11.65M
Volume
0
Short Interest
0.00%
Avg. Volume
478.00K
Financials (TTM)
Gross Profit
$31.59M
Operating Income
$11.35M
EBITDA
$10.48M
Operating Cash Flow
$13.36M
Capital Expenditure
$2.00K
Free Cash Flow
$13.36M
Cash & ST Invst.
$6.39M
Total Debt
$6.16M
Biofrontera Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$17.10M
+36.2%
Gross Profit
$14.37M
+97.1%
Gross Margin
84.01%
N/A
Market Cap
$9.59M
N/A
Market Cap/Employee
$104.27K
N/A
Employees
92
N/A
Net Income
$5.64M
+504.0%
EBITDA
$4.78M
+525.5%
Quarterly Fundamentals
Net Cash
$231.00K
-76.7%
Accounts Receivable
$7.29M
+37.2%
Inventory
$1.43M
-78.5%
Long Term Debt
$5.83M
+33.3%
Short Term Debt
$332.00K
-39.4%
Return on Assets
-36.89%
N/A
Return on Invested Capital
-68.07%
N/A
Free Cash Flow
$2.38M
-133.3%
Operating Cash Flow
$2.38M
-133.6%

